Medical Physics Present and Future
Medical Physics Present and Future
Medical Physics Present and Future
BOTi=PDi/100 x T100,d,FS
The 90’s – the era of 3D
Perez and Brady - Principles and Practice of Radiation Oncology-1998, and others…
Cranio- spinal Irradiation
RFS vs. DOSE - RT alone
Tumour Control
Probability
(TCP)
Normal Tissue
Toxicity (NTCP) Courtesy: Dr Jacob (Jake) Van Dyk
Radiation Oncology Historical Trends
Clinical Benefit
(Survival)
(Conformality)
1.0
1895-1940s 1950s 1960s-70s 1970s-80s 1990s-2019 >2020s
100-400 kV x-rays Cobalt-60 Multi-energy CT, 3D-CRT IMRT, IGRT, ART, PET, MR-
0.9
Non-uniform dose MV x-rays linacs Brachytherapy IGRT, Protons, Carbon ions
Next??
High skin dose Skin sparing Computerized afterloading
0.8 Brachytherapy Uniform dose TPSs
Radium & radon Manual treatment Simulators
??
Calculation systems planning
0.7
0.6 CT
0.5 2010s
Linear
“Real data” Survival=67%
0.4 accelerators
1970s
Cobalt-60
0.3 Brachytherapy
Survival=50%
Discovery of x-
Fractionation
rays &
0.2 radioactivity
0.1
0.0
1895 1910 1920 1930 1940 1950 1960 1970 1980 1990 2000 2010 2020 2030 2040
Year Courtesy: Dr Jacob (Jake) Van Dyk
USA 5-yr Survival: 1970s [] to 2010s []
• All cancers up
• 50% 67%
• Except cervix &
uterus
• Prostate
• 68% 99%
• “early detection
and improved
Our World in Data, University of Oxford
https://ourworldindata.org/uploads/2018/03/Five
treatment”
-year-cancer-survival-rates-USA-v2-01.png
Gold coils implanted in the prostate are shown on a DRR (a) and on an MV portal
image (b). Image matching structures obtained from the DRR are superimposed on
the EPID to target the coils, rather than the bony anatomy.
Image guidance over the years
• On Board imagers (kV and MV)
Localization and 4D RF Tracking of Implanted Markers
Optical System
4D Localization System
Infrared Cameras
4D Electromagnetic
Array
4D Tracking Station
Optical Targets
4D Console
Implanted
Beacon® Electromagnetic
Transponders
Image guidance over the years
• U-Sound targeting (mainly
distance or interface)
Image guidance over the years
• Optical surface
matching (Visionrt)
Multimodality image registration
Autocontouring
Big Little
difference difference
From:
Moe Siddiqui
April 08, 2017
RaySearch Labs
http://pubs.medicaldosimetry.org/pub/e5a
d0d52-782b-cb6e-2763-e6a918540f5c
Adaptive technologies
• Image warping
• Daily-re-optimization
• Daily dose accumulation
• Real-time tracking of tumor markers
• Real-time tracking and correction of MLC
apertures
More Adaptation … example
• Tissue voxels move/change from day to day
Source Target
46
Result Target
Treatment fraction 1
Planned
47
Laser
volume.
2005
2005
From Dr Jacob (Jake) Van Dyk
Technology advantages
• More efficient
Halcyon
• VMAT, TomoTherapy, Halcyon
Example: Installation, commissioning, training
TrueBeam
Courtesy
T.F. Atwood, UCSF
Sept 2018
Technology advantages
• More efficient
Halcyon
• IMAT, TomoTherapy, Halcyon
Example: Patient throughput
6 pts/hr
TrueBeam
3.5 pts/hr
Courtesy
T.F. Atwood, UCSF
Sept 2018
Trends Over the Next 10 Years
• More particles
70
Proton Therapy Facilities
60
• Proton therapy
40
30
• 11 carbon ion facilities (2017) Figure courtesy Thomas Bortfeld … source: PTCOG
• 6 in Japan
“Conservative Estimate”
• 10% of the patients who require radiation
would benefit from proton therapy
• From Thomas Bortfeld, MGH (2018)
• “… 10-20% of patients receiving radiotherapy
might benefit from charged particle beams.”
• From Jones & Burnet, BMJ 330: 979-980; 2005
More Compact … Shrinking Proton Accelerators
US FDA Cleared
Proton Therapy
Systems
1946
Harvard
(700 tons)
1996
IBA/Sumitomo
(220 tons)
2000
Varian/Accel
(90 tons) 2012
Courtesy: Mevion Mevion Medical
Slide courtesy Thomas Bortfeld Systems (<20 tons)
Trends Over the Next 10 Years
• More hypofractionation (higher
doses/fraction, SBRT)
• Breast cancer
Timeline of UK Breast RT Trials